// App-Quantinova.ai

4521 : FDG PET scan (PET) positive residual lesions after chemotherapy (chemo) for metastatic seminoma: Results of an International Global Germ Cell Cancer Group (G3) registry.

Researchers

Presenter

  • Richard Cathomas

Principal Investigators

  • Brandon David Bernard

  • Anja Lorch

  • Xavier Garcia del Muro

  • Franco Morelli

  • Ugo De Giorgi

  • Mikhail Fedyanin

  • Christoph Oing

  • Hege Sagstuen Haugnes

  • Marcus Hentrich

  • Christian Daniel Fankhauser

  • Margarida Brito Goncalves

  • Gabriella Elisabeth Cohn-Cedermark

  • Gedske Daugaard

  • Giuseppe Fornarini

  • Gaetano Aurilio

  • Frank Mayer

  • Katharina Huss

  • Joerg Beyer

Medical Centers

  • Kantonsspital Chur, Chur, Switzerland

  • SAKK - Swiss Group for Clinical Cancer Research, Coordinating Center, Bern, Switzerland

  • Dana-Farber Cancer Institute, Boston, MA

  • Heinrich-Heine-Universitat, Dusseldorf, Germany

  • Institut Catala d'Oncologia, l'Hospitalet de Llobregat, Barcelona, Spain

  • Medical Oncology, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, San Giovanni Rotondo, Italy

  • Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

  • N. N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia

  • University Hospital Eppendorf Frauenklinik, Hamburg, Germany

  • University Hospital of North Norway, Tromso, Norway

  • Harlaching Hospital University of Munich, Munich, Germany

  • University Hospital of Zurich, Zurich, Switzerland

  • Instituto Portugues de Oncologia de Lisboa, Lisbon, Portugal

  • Karolinska Institutet, Karolinska University Hospital and SweBCG, Stockholm, Sweden

  • NSGO & Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark

  • Medical Oncology, Ospedale San Martino, Genova, Genova, Italy

  • Medical Oncology Division of Urogenital and Head and Neck Tumors, European Institute of Oncology, Milan, Italy

  • University Hospital, Medical Center II, Tuebingen, Germany

Locations

  • Italy

  • Norway

  • Germany

  • Spain

  • Switzerland

  • United States

  • Portugal

  • Russia

  • Denmark

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • 18F-fluorodeoxyglucose

  • Alpha-fetoprotein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved